Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function - PubMed (original) (raw)

Review

Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function

Thiago Thomaz Mafort et al. Multidiscip Respir Med. 2016.

Abstract

Obesity is currently one of the major epidemics of this millennium and affects individuals throughout the world. It causes multiple systemic complications, some of which result in severe impairment of organs and tissues. These complications involve mechanical changes caused by the accumulation of adipose tissue and the numerous cytokines produced by adipocytes. Obesity also significantly interferes with respiratory function by decreasing lung volume, particularly the expiratory reserve volume and functional residual capacity. Because of the ineffectiveness of the respiratory muscles, strength and resistance may be reduced. All these factors lead to inspiratory overload, which increases respiratory effort, oxygen consumption, and respiratory energy expenditure. It is noteworthy that patterns of body fat distribution significantly influence the function of the respiratory system, likely via the direct mechanical effect of fat accumulation in the chest and abdominal regions. Weight loss caused by various types of treatment, including low-calorie diet, intragastric balloon, and bariatric surgery, significantly improves lung function and metabolic syndrome and reduces body mass index. Despite advances in the knowledge of pulmonary and systemic complications associated with obesity, longitudinal randomized studies are needed to assess the impact of weight loss on metabolic syndrome and lung function.

Keywords: Lung function; Metabolic syndrome; Obesity.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Pulmonary function abnormalities resulting from obesity

Similar articles

Cited by

References

    1. World Health Organization, WHO, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation (WHO Technical Report Series 894) at http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/. Accessed 10 Feb 2016. - PubMed
    1. Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13:423–44. doi: 10.1089/met.2015.0095. - DOI - PMC - PubMed
    1. Brazilian Association for the Study of Obesity and Metabolic Syndrome, ABESO, Brazilian Obesity Guidelines 2009/2010 at http://www.abeso.org.br/pdf/diretrizes_brasileiras_obesidade_2009_2010_1.... Accessed 22 Jan 2016.
    1. de Oliveira ML, Santos LM, da Silva EN. Direct healthcare cost of obesity in Brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011. PLoS One. 2015;10:e0121160. doi: 10.1371/journal.pone.0121160. - DOI - PMC - PubMed
    1. Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16:378–400. doi: 10.3390/ijms16010378. - DOI - PMC - PubMed

Publication types

LinkOut - more resources